Human Epigenome Project
Human Epigenome Project (HEP) is a multinational science project, with the stated aim to "identify, catalog, and interpret genome-wide DNA methylation patterns of all human genes in all major tissues".[1] It is financed by government funds as well as private investment, via a consortium of genetic research organisations.
The call for such a project was widely suggested and supported by cancer research scientists from all over the world.[2][3][4][5]
Consortium
The HEP consortium is made up of the following organizations:
- The Wellcome Trust Sanger Institute — UK
- Epigenomics AG — Germany/USA
- The Centre National de Génotypage — France
References
- ↑ "Description Page". Human Epigenome Project. Retrieved 2009-01-30.
- ↑ Esteller M (2006). "The necessity of a human epigenome project". Carcinogenesis. 27 (6): 1121–1125. PMID 16699174. doi:10.1093/carcin/bgl033.
- ↑ Jones PA, Martienssen R (2005). "A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop". Cancer Res. 65 (24): 11241–11246. PMID 16357125. doi:10.1158/0008-5472.CAN-05-3865.
- ↑ Rauscher FJ 3rd (2005). "It is time for a Human Epigenome Project". Cancer Res. 65 (24): 11229. PMID 16357122. doi:10.1158/0008-5472.can-65-24-ed1.
- ↑ Bradbury J (2003). "Human epigenome project--up and running". PLoS Biol. 1 (3): E82. PMC 300691
. PMID 14691553. doi:10.1371/journal.pbio.0000082.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.